Clinical trial Recruiting at 6 sites Interventional Ages 18 to 64

Tele-group CBT for families of people with schizophrenia

Official title: Effectiveness of a Tele-group Cognitive Behavioural Family Intervention (tgCBFI) for People With Schizophrenia and Their Families: a Mixed-method Study

Run by The Hong Kong Polytechnic University · NCT07121166 · Data updated 2026-11-12

A online group program tests whether a family-based cognitive behavioral intervention delivered to people with schizophrenia and their family members can help reduce caregiver stress and improve symptoms for patients.

Quick facts

Study typeInterventional
Ages18 Years to 64 Years
SexAll
Enrollment200 (estimated)
SponsorThe Hong Kong Polytechnic University
Academic / other
Locations6 sites (Chai Wan and 5 other locations)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedMay 31, 2028
Study endsJuly 31, 2028
Registry record updatedJuly 24, 2026
Trial IDNCT07121166 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with schizophrenia-spectrum disorders (18-64) who can read and write Chinese and live with a family caregiver able to participate.

Probably not a fit

Individuals who do not have a participating family caregiver or cannot meet language and living arrangement criteria may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study uses a mixed-methods design to test a tele-delivered cognitive behavioral family intervention (tgCBFI) for dyads of individuals with schizophrenia and their family caregivers. It includes a randomized controlled trial with a 12-week post-intervention follow-up and qualitative focus groups to understand perceived benefits. The trial compares tgCBFI plus treatment as usual to treatment as usual alone, measuring caregiver mood and burden, patient expressed emotion, and patient symptom changes. Quantitative outcomes will be complemented by qualitative data from service users and caregivers to provide deeper insight into how the intervention works. The study builds on evidence that family interventions can reduce relapse risk and caregiver distress by addressing cognitive reactions and family dynamics.

Why it matters

Potential benefit: If successful, participants could experience reduced caregiver burden and mood disturbances, and patients may show lower expressed emotion and symptom severity.

How similar studies have gone: Previous meta-analyses support family interventions for relapse prevention and caregiver well-being, suggesting potential benefit for this tele-delivered approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
I. Individuals with schizophrenia-spectrum disorders

Inclusion Criteria:

* current diagnosis of schizophrenia-spectrum disorders, based on ICD-10 made by the treating clinicians,
* aged 18-64, and
* able to read and write Chinese

Exclusion Criteria:

* having co-morbidity of learning disability, organic/neurological conditions, or substance use disorder, and
* living in a hostel

II. Family caregivers

Inclusion Criteria:

* aged 18 or above,
* able to read and write Chinese,
* live with service users, and
* nominated by the service users

Exclusion Criteria:

* having active psychiatric conditions

Where it's running

  • ALOHA (Eastern)
    Chai Wan, Hong Kong
    Recruiting
  • Kowloon Hospital
    Kowloon City, Hong Kong
    Recruiting
  • Kwai Chung Hospital
    Kwai Chung, Hong Kong
    Recruiting
  • United Christian Hospital
    Kwun Tong, Hong Kong
    Recruiting
  • Queen Mary Hospital
    Pokfulam, Hong Kong
    Recruiting
  • ALOHA (Wong Tai Sin)
    Tsz Wan Shan, Hong Kong
    Recruiting

Study contacts

  • Principal investigator: Dennis Chak Fai Ma, PhD — School of Nursing, The Hong Kong Polytechnic University
  • Study coordinator: Dennis Chak Fai Ma, PhD
  • Email: dennis.cf.ma@polyu.edu.hk
  • Phone: 852-27666555

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.